Health
Tigerlily Foundation Collaborates with Bristol Myers Squibb to Advance Clinical Trial Access and Equity
Tigerlily Foundation, a leading national breast cancer nonprofit dedicated to ending cancer disparities for young women—particularly women of color—today announced a collaboration with Bristol Myers Squibb (BMS) focused on expanding access to clinical trials and reducing barriers to participation.
About this update from Bristol-myers Squibb Company
[{"type":"text","content":"National Breast Cancer Nonprofit Highlights Efforts to Reduce Barriers for Patients, Especially Women of Color","length":110,"tagName":"p"},{"type":"text","content":"WASHINGTON, May 15, 2026 /PRNewswire/ -- Tigerlily Foundation, a leading national breast cancer nonprofit dedicated to ending cancer disparities for young women—particularly women of color—today announced a collaboration with Bristol Myers Squibb (BMS) focused on expanding access to clinical trials and reducing barriers to participation.","length":339,"tagName":"p"},{"type":"image","alt":"Tigerlily Logo (PRNewsfoto/TIGERLILY FOUNDATION)","displaySize":"","headline":null,"caption":"Tigerlily Logo (PRNewsfoto/TIGERLILY FOUNDATION)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":141,"url":"https://media.zenfs.com/en/prnewswire.com/2c30644db9c57b9dfc036c21d4006f77"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QkgWIUo9xSHrVG5xjgmO2A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI0OQ--/https://media.zenfs.com/en/prnewswire.com/2c30644db9c57b9dfc036c21d4006f77","width":400,"height":141},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/r.iCJC_74G2GrwB7pAl9rQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTIyNg--/https://media.zenfs.com/en/prnewswire.com/2c30644db9c57b9dfc036c21d4006f77","width":400,"height":141}},"href":"https://mma.prnewswire.com/media/2838970/TIGERLILY_FOUNDATION_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"This work is part of Tigerlily's ONE in a MILLION campaign (#ONEinaMILLION), which aims to reach one million women with education and empowerment around clinical trials. Clinical research remains essential for developing new treatments and improving standards of care for breast cancer. This campaign helps individuals learn more about and connect to clinical trial opportunities, including studies in triple-negative breast cancer (TNBC).","length":443,"tagName":"p"},{"type":"text","content":"Through this collaboration, Tigerlily Foundation and Bristol Myers Squibb (BMS) are working to increase awareness, education, and engagement around clinical research, with a shared commitment to improving access for communities that have historically been underrepresented in this space. These efforts provide patients with clear, accessible information about their care options while addressing common partic...